HIGHLIGHTS
- who: Yudi Zhang from the (UNIVERSITY) have published the Article: Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms, in the Journal: (JOURNAL) of August/30,/2016
- how: The authors used a dataset of 852 consecutive subjects with MDS initially diagnosed using the WHO 2016 criteria to compare how these subjects would be classified using the WHO 2022. A combination of flow antibody panel was designed to assess MDS associated phenotypic abnormalities according to
SUMMARY
Diagnostic criteria for MDS with low . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.